Literature DB >> 6333574

Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids.

J N Beresford, J A Gallagher, J W Poser, R G Russell.   

Abstract

Cells have been cultured from human bone that possess several characteristics of osteoblasts, including the capacity to produce osteocalcin (bone Gla protein). In these cultures the production of osteocalcin is dependent on 1,25(OH)2D3 but is not affected by 24,25(OH)2D3 either alone or in combination with 1,25(OH)2D3. Two glucocorticoids, prednisolone and deflazacort, reverse the stimulation of osteocalcin synthesis by 1,25(OH)2D3 in a dose-dependent manner (10(-9) - 10(-6)M). Parathyroid hormone also inhibits osteocalcin production in a dose-dependent fashion (0.2-5 IU/ml). These results demonstrate that human bone cell cultures may be of considerable value in investigating the hormonal and pharmacologic regulation of the production of osteocalcin and other bone proteins in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333574     DOI: 10.1016/0221-8747(84)90064-x

Source DB:  PubMed          Journal:  Metab Bone Dis Relat Res        ISSN: 0221-8747


  66 in total

1.  A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone.

Authors:  Richard Tuli; M Reza Seghatoleslami; Suraj Tuli; Mark L Wang; William J Hozack; Paul A Manner; Keith G Danielson; Rocky S Tuan
Journal:  Mol Biotechnol       Date:  2003-01       Impact factor: 2.695

2.  Generation of rodent and human osteoblasts.

Authors:  Sarah E B Taylor; Mittal Shah; Isabel R Orriss
Journal:  Bonekey Rep       Date:  2014-11-12

3.  Characterization of endosteal osteoblasts isolated from human maxilla and mandible: an experimental system for biocompatibility tests.

Authors:  P Doglioli; G Scortecci
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

4.  Effects of a short course of oral phosphate treatment on serum parathyroid hormone(1-84) and biochemical markers of bone turnover: a dose-response study.

Authors:  K Brixen; H K Nielsen; P Charles; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

5.  A novel spectrofluorometric technique for specific biocompatibility testing of implantable materials by cell culture. Report on use for multiparameter analysis of human osteoblasts cultured on commercially pure titanium and hydroxyapatite.

Authors:  P Doglioli; G Scortecci; M Falatouni
Journal:  Cytotechnology       Date:  2001-03       Impact factor: 2.058

6.  [In vitro trials with single and co-cultures of osteoblasts and endothelial cells : evaluation of new biomaterials for bone reconstruction and regeneration].

Authors:  R E Unger; S Halstenberg; H Günther; A Sartoris; C Brochhausen; C J Kirkpatrick
Journal:  Orthopade       Date:  2009-11       Impact factor: 1.087

7.  Talc granulomatosis in the rat. Involvement of bone in the acute-phase response.

Authors:  A Marusić; K Kos; A Stavljenić; S Vukicević
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

8.  Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age.

Authors:  O M Lepage; M Marcoux; A Tremblay
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

9.  Proliferative responses to estradiol, IL-1 alpha and TGF beta by cells expressing alkaline phosphatase in human osteoblast-like cell cultures.

Authors:  D J Rickard; M Gowen; B R MacDonald
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

10.  Measurement of intracellular Ca2+ in single aequorin-injected and suspensions of fura-2-loaded ROS 17/2.8 cells and normal human osteoblasts. Effect of parathyroid hormone.

Authors:  C Schöfl; K S Cuthbertson; J A Gallagher; S R Pennington; P H Cobbold; G Brabant; R D Hesch; A von zur Mühlen
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.